Replace Olympia Pharmacy with pass-through pricing

When clinic-agreement pricing breaks — replace it with pass-through

Replacing Olympia Pharmacy's ordering model with pass-through pricing makes sense when a clinic-agreement, quote-first model stops fitting how you run margin. Olympia Pharmacy sets pricing through clinic agreements negotiated at onboarding through the DrScript portal; clinics typically need to contact Olympia for a custom quote before the per-vial rate becomes visible. A pass-through platform like Fizy Health inverts that: resolved 503A landed cost appears on each catalog and cart line before checkout, with a disclosed facilitation fee at payment — so a clinic can quote a cash-pay patient on real numbers the same session, without a sales call. The choice is not about Olympia Pharmacy's formulary quality; it is about whether the pricing model fits the moment a clinician quotes a patient.

If you cannot see per-vial cost until after a quote or cannot confirm landing cost at point of sale, this page explains how pass-through pricing differs from a clinic-agreement model and the concrete signals that it is time to replace it.

Proudly Partnered With

Clinic-agreement pricing versus pass-through, plainly

A clinic-agreement model sets your drug cost through a negotiation at onboarding. Olympia Pharmacy offers pricing through its DrScript portal and clinical liaison process — the per-vial rate arrives after you contact Olympia and complete onboarding, not at the point you are first evaluating the platform or quoting a patient. That can produce competitive rates for high-volume clinics with an established relationship, which is a real strength. The cost is timing and visibility: you do not see the number at the moment you are quoting a patient on semaglutide or tirzepatide, and re-checking a rate if volume or SKU mix changes means another conversation.

A pass-through model inverts that. With Fizy Health, the resolved 503A landed cost appears on each catalog and cart line before checkout, and the platform's margin is a disclosed facilitation fee at payment rather than an opaque per-vial spread. The drug cost is what the 503A pharmacy charges; the platform fee is stated separately. For a clinic quoting cash-pay GLP-1, peptide, or hormone patients daily, that means the price you quote and the price you pay are the same visible number — no markup layer obscured inside the vial cost, no waiting on a revised quote.

Signs it is time to replace a clinic-agreement model

Replace a clinic-agreement model when the lack of upfront pricing actively slows your clinic. Common signals: you delay quoting a new patient because you are waiting on a rate confirmation; you cannot set cash-pay prices confidently because landed cost is not visible at point of sale; you suspect a per-vial spread but cannot separate drug cost from platform margin in your current invoices; or your SKU mix or volume has shifted and you are unsure whether your negotiated rate still reflects it without re-engaging sales.

Another signal is operational: if paid orders are rejected after checkout for SIG or licensure errors, the pricing question compounds with a validation gap. A pass-through platform like Fizy Health pairs visible per-vial cost with pre-submit cart validation — the same workflow that shows your per-vial margin also catches invalid SIGs, prescriber state mismatches, and stock gaps before you pay. If none of these signals apply — your Olympia Pharmacy rates are competitive and DrScript fits your daily cadence — a clinic-agreement model may still be the right fit. Replace it when the model, not the formulary, is the constraint.

Keep Olympia Pharmacy's clinic-agreement model, or replace it with pass-through pricing?

Keep Olympia Pharmacy's model if

Olympia Pharmacy

Your negotiated clinic-agreement rate already wins on your top SKUs.

  • Your Olympia Pharmacy clinic-agreement rates beat pass-through cost on the peptide, GLP-1, and hormone lines you order most.
  • You do not need per-vial cost at the moment you quote patients, and re-quoting through the liaison process is acceptable.
  • Olympia's 503B office-use batch options or overnight shipping economics are central to how your clinic runs.
Replace it with Fizy Health if

Fizy Health

You need the per-vial number before you quote — every time.

  • You quote cash-pay patients daily on semaglutide, peptides, or hormones and need landed 503A cost visible before checkout.
  • You want drug cost and a disclosed facilitation fee separated — not a spread embedded in the vial cost.
  • You want pre-submit validation paired with visible pricing so paid orders stop being rejected.
FAQ

Common questions about replacing a clinic-agreement model with pass-through pricing.

  • Definition

    What does pass-through pricing mean for clinic ordering?

    Pass-through pricing means the drug cost you pay is what the 503A pharmacy charges, shown per vial on each catalog and cart line before checkout, with the platform's margin disclosed separately as a facilitation fee at payment rather than hidden inside the vial cost.

  • Comparison

    How is pass-through different from Olympia Pharmacy's pricing model?

    Olympia Pharmacy sets drug pricing through clinic agreements negotiated at onboarding via DrScript; per-vial rates are visible after you complete that process, not from the catalog before you sign up. Pass-through pricing on Fizy Health shows resolved 503A landed cost on each line in catalog and cart, with a disclosed facilitation fee, so you quote on real numbers without a prior sales conversation.

  • Trigger

    When should I replace Olympia Pharmacy's clinic-agreement model?

    Replace it when the lack of upfront pricing slows you down: you delay quoting patients while waiting on a rate, you cannot set cash-pay prices confidently because landed cost is not visible at the point of sale, or you cannot separate drug cost from platform margin in your invoices.

  • Strengths

    Is a clinic-agreement model ever the better choice?

    Yes. A negotiated clinic-agreement rate can produce competitive per-vial pricing at high volume, especially when you have an established Olympia Pharmacy relationship and Olympia's peptide or NAD+ formulary covers your needs. If your negotiated rates already beat pass-through cost on your top SKUs, stay with that model.

  • Validation

    Does pass-through pricing also help with rejected orders?

    On Fizy Health, visible pricing is paired with pre-submit cart validation. The same workflow that shows your per-vial margin also catches invalid SIGs, prescriber state mismatches, and stock gaps before you pay — so fewer paid orders get rejected by the pharmacy.

  • Proof

    How do I verify pass-through pricing is actually cheaper?

    Open the Fizy Health catalog and cart for your highest-volume GLP-1, peptide, and hormone lines and compare pass-through per-vial cost against the landed cost from your current Olympia Pharmacy clinic-agreement rates. If it does not beat your negotiated rates on the lines you order most, do not switch.

Sources reviewed June 2026

  • Olympia Pharmacy public website and DrScript prescriber portal (olympiapharmacy.com, olympiapharmacy.drscriptportal.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See pass-through pricing on your top SKUs — no quote required.

Compare landed cost on semaglutide, tirzepatide, and your peptide lines, run one validated batch cart, and decide with real numbers. Free to start.